Listen: PITTSBURGH, April 23, 2025 – PRISM MediaWire – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “we,” “our,” or the “Company”), a clinical-stage biotechnology company focused
Listen: PITTSBURGH, April 22, 2025 – PRISM MediaWire – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us,” or the “Company”), a clinical-stage biotechnology company addressing
Listen: New York, NY, April 22, 2025 – PRISM MediaWire – Creatd, Inc. (OTC: CRTD), a diversified holding company scaling growth through strategic acquisitions, has
Meeting the rigorous regulatory standards required by international markets Listen: HAUPPAUGE, N.Y., April 21, 2025 – PRISM MediaWire – AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW),
Listen: CUPERTINO, Calif., April 21, 2025 – PRISM MediaWire – Aemetis, Inc. (NASDAQ: AMTX), a diversified global renewable natural gas and biofuels company, announced the Company’s
Milestone Event Signals Readiness for Phase I Testing and Positions UAV Corp to Execute on Over $500M in Strategic LOIs WEWAHITCHKA, Fla., April 21, 2025
Seasoned Executive to Lead Operational and Strategic Growth Initiatives WEWAHITCHKA, Fla., April 17, 2025 – PRISM MediaWire – UAV Corp (OTC: UMAV), an emerging leader in dual-use
New York, NY, April 17, 2025 – PRISM MediaWire – Creatd’s (OTC: CRTD) wholly-owned subsidiary Flyte, formerly known as Flewber, today announced the official launch
HAUPPAUGE, N.Y., April 16, 2025 – PRISM MediaWire – AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a leading designer, developer, and manufacturer of advanced signal processing
Feature Details Company Milestones and 2025 Catalysts Across Gene Therapy and Ophthalmic Programs NEW YORK, April 15, 2025 – PRISM MediaWire – PRISM MarketView today
PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850
